Author details

Full Name

Marie B D'hooghe

Affiliation

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36851894	Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.		2023
37672569	The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis.		2023
37326133	Reduced alpha2 power is associated with slowed information processing speed in multiple sclerosis.		2023
36803643	Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis.	Gut Microbes	2023
35330433	Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring.	Journal of Personalized Medicine	2022
36369488	Social determinants of health in multiple sclerosis.	Nature Reviews Neurology	2022
36104820	Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial.	Trials	2022
35737867	Brain age as a surrogate marker for cognitive performance in multiple sclerosis.	European Journal of Neurology	2022
35931796	Correlates of patient-reported cognitive performance with regard to disability.	Scientific Reports	2022
36059263	Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.	Multiple Sclerosis Journal	2022
36526708	Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis.		2022
35159972	Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity.	Journal of Clinical Medicine	2022
33242237	Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis.	Human Brain Mapping	2021
33795779	Signal quality as Achilles' heel of graph theory in functional magnetic resonance imaging in multiple sclerosis.	Scientific Reports	2021
34157999	SativexÂ® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.	BMC Neurology	2021
33770549	Increased brain atrophy and lesion load is associated with stronger lower alpha MEG power in multiple sclerosis patients.	NeuroImage: Clinical	2021
33247542	The role of hippocampal theta oscillations in working memory impairment in multiple sclerosis.	Human Brain Mapping	2021
32564270	Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.	Neurological Sciences	2020
31908773	Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.	Translational Neurodegeneration	2020
32180307	Spatiotemporal and spectral dynamics of multi-item working memory as revealed by the n-back task using MEG.	Human Brain Mapping	2020
32162850	Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.	Ann Clin Transl Neurol	2020
31981931	Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis.	Multiple Sclerosis and Related Disorders	2020
32447274	Feasibility of Real Time Internet-Based Teleconsultation in Patients With Multiple Sclerosis: Interventional Pilot Study.	Journal of Medical Internet Research	2020
33298133	Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial.	Trials	2020
31361073	Altered transient brain dynamics in multiple sclerosis: Treatment or pathology?	Human Brain Mapping	2019
31723322	The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis.		2019
31827784	Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.	Translational Neurodegeneration	2019
31877665	Stronger Correlations between Neurophysiological and Peripheral Disease Biomarkers Predict Better Prognosis in Two Severe Diseases.	Journal of Clinical Medicine	2019
31861312	Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis.	Journal of Clinical Medicine	2019
30597656	Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.	Journal of Magnetic Resonance Imaging	2019
31183915	Perceived neuropsychological impairment inversely related to self-reported health and employment in multiple sclerosis.	European Journal of Neurology	2019
31081475	Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.	Multiple Sclerosis Journal	2019
31218911	Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.	Multiple Sclerosis Journal	2019
29543871	The effect of task modality and stimulus frequency in paced serial addition tests on functional brain activity.	PLoS ONE	2018
30411658	Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version.	Multiple Sclerosis Journal	2018
29649789	Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.	Multiple Sclerosis and Related Disorders	2018
29260023	Definition, prevalence and predictive factors of benign multiple sclerosis.	eNeurologicalSci	2017
28786335	Electronic visual analogue scales for pain, fatigue, anxiety and quality of life in people with multiple sclerosis using smartphone and tablet: a reliability and feasibility study.	Clinical Rehabilitation	2017
29141818	Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study.	Multiple Sclerosis and Related Disorders	2017
27761897	Self-reported levels of education and disability progression in multiple sclerosis.	Acta Neurologica Scandinavica	2016
27182847	The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.	International Journal of Rehabilitation Research	2016
26362898	A 10-year follow-up of the European multicenter trial of interferon Î²-1b in secondary-progressive multiple sclerosis.	Multiple Sclerosis Journal	2016
26530512	Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.	J Neurol	2016
25013149	Reduced information processing speed as primum movens for cognitive decline in MS.	Multiple Sclerosis Journal	2015
25801923	The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods.	Disability and Rehabilitation	2015
25786475	How to conquer a mountain with multiple sclerosis. How a climbing expedition to Machu Picchu affects the way people with multiple sclerosis experience their body and identity: a phenomenological analysis.	Disability and Rehabilitation	2015
26104292	Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?	Journal of Cerebral Blood Flow and Metabolism	2015
25086173	Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.	Journal of Immunology	2014
25344546	Multiparity in women with multiple sclerosis causes less long-term disability: yes.	Multiple Sclerosis Journal	2014
24460863	Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.	Trials	2014